Stock TORNTPHARM TORRENT PHARMACEUTICALS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Torrent Pharmaceuticals Limited NSE India S.E.

Equities

TORNTPHARM

INE685A01028

Market Closed - NSE India S.E.
Other stock markets
 07:43:49 2024-04-18 am EDT 		5-day change 1st Jan Change
2,547 INR +0.36% Intraday chart for Torrent Pharmaceuticals Limited -1.24% +10.47%
Apr. 08 Torrent Pharmaceuticals Limited Receives an Order Passed Under Section 73 of the Goods and Service Act, 2017, Imposing A Penalty of INR 388,809.60 CI
Apr. 01 Torrent Pharmaceuticals Limited Announces Change in Directorate , Effective 31 March 2024 CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Torrent Pharmaceuticals Limited Receives an Order Passed Under Section 73 of the Goods and Service Act, 2017, Imposing A Penalty of INR 388,809.60
CI
Torrent Pharmaceuticals Limited Announces Change in Directorate , Effective 31 March 2024
CI
Torrent Pharmaceuticals Limited Announces Superannuation of Ashok Modi as Executive Director
CI
Ex-dividend day for interim dividend
FA
Nomura Adjusts Torrent Pharmaceuticals' Price Target to INR2,975 From INR2,156, Keeps at Buy
MT
Supernus Wins Infringement and Validity Case on Trokendi XR against Torrent
AQ
Supernus Says US District Court Rules Torrent Pharmaceuticals Infringed Patents
MT
Jefferies Adjusts Torrent Pharmaceuticals' Price Target to INR2,930 From INR2,750, Keeps at Buy
MT
Torrent Pharmaceuticals Posts Gains in Fiscal Q3 Consolidated Net Profit
MT
Torrent Pharmaceuticals' Consolidated Profit in Fiscal Q3
MT
Transcript : Torrent Pharmaceuticals Limited, Q3 2024 Earnings Call, Feb 02, 2024
India's Torrent Pharma posts higher Q3 profit on strong domestic demand
RE
Torrent Pharmaceuticals Limited Announces Interim Dividend, Payable on or around 23 February, 2024
CI
Torrent Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
India's Glenmark Life Sciences posts Q3 profit rise; strong orderbook ahead, says CEO
RE
Torrent Pharmaceuticals Forms New Wholly-Owned Arm in Colombia
MT
Torrent Pharmaceuticals' Oral Oncology Plant Gets Fives Observations from US FDA
MT
Zydus Lifesciences Limited and Torrent Pharmaceuticals Limited Enter into Licensing and Supply Agreement to Co-Market, Saroglitazar Mg
CI
Nomura Adjusts Torrent Pharmaceuticals Price Target to INR2,156 From INR2,199, Keeps at Buy
MT
Torrent Pharmaceuticals' Consolidated Profit Climbs in Fiscal Q2; EPS, Revenue Meet Estimates
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. TORNTPHARM Stock
  4. TORNTPHARM Stock
  5. News Torrent Pharmaceuticals Limited